Amedisys Inc. AMED

NAS: AMED | ISIN: US0234361089 12/11/2024

91,00 USD (-1,81%)

(-1,81%) 12/11/2024

Toon enkel gratis nieuws

5 juli 2023 · Moore Kuehn Encourages AMED, KLR, SGTX, and WAKE Investors to Contact Law Firm · Persbericht

3 mei 2023 · Amedisys Reports First Quarter 2023 Financial Results And Updates 2023 Guidance · Persbericht

3 mei 2023 · Option Care Health and Amedisys to Combine Creating a Leading, Independent Platform for Home and Alternate Site Care · Persbericht

9 maart 2023 · Amedisys and nVoq Present Outcomes from Speech Recognition Study at PALTC23 Conference · Persbericht

18 november 2022 · Amedisys Confirms Full Year Guidance · Persbericht

17 november 2022 · Amedisys Announces CEO Departure · Persbericht

23 februari 2022 · Virginia Mason Franciscan Health Collaborates with Contessa to Bring Hospital-Level Care into Patients' Homes · Persbericht

10 november 2021 · Penn State Health Partners with Highmark Health and Contessa to Launch Home Recovery Care, a new At-Home Option for Patients · Persbericht

15 maart 2021 · Amedisys Repurchases Approximately $73 Million of Stock Under Previously Authorized $100 Million Share Repurchase Program · Persbericht

1 maart 2021 · Amedisys to Present at Two Virtual Investor Conferences · Persbericht

9 februari 2021 · Amedisys Announces Fourth Quarter and Year End Earnings Release and Conference Call Date · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe